The problem of the quality of primary health care medical system for patients with arterial hypertension is acute for the investigator's country, as these diseases are the most common and cause the high mortality of the population.
The concept of "quality of primary health care medical system" includes its timeliness, accessibility and provision of medical care to the patient at the modern level, which is determined by the degree of performance by doctors of medical and diagnostic measures corresponding current clinical recommendations.
The system of cardiovascular desease registries, established in the Federal State Clinical Hospital of the Russian Federation Ministry of Public Health with the automated analysis of data on examination and treatment, in comparison with clinical Recommendations. It makes possibility to identify shortcomings and develop approaches to improving the provision of medical care to patients in real clinical practice.
Comparative analysis of the quality of examination and treatment in different samples of patients with cardiovascular desease, observed in 2018-2020, compared with results of previous years will identify ptrends in the provision of medical care to patients with cardiovascular desease.
None
None
outpatient patients from 18 to 99 years old with a diagnosis of hypertension
Cohort
Cross-sectional
Not listed
Number of patients with blood pressure <140/90 mm Hg
The level of systolic and diastolic blood pressure measured according to the rules described in the clinical guidelines for the treatment and diagnosis of arterial hypertension of the European Society of Cardiology during the visit (mmHg) is entered into the database by doctors.
Number of patients with a history of myocardial infarction, chronic renal desease, chronic heart failure, atrial fibrillation.
Diagnosis data is entered by doctors as a "yes" or "no" category.
Antihypertensive medications
Antihypertensive drugs the patient takes are entered into the database. Drugs are analyzed by groups and daily dosages
Click on the lead sponsor to view all of their trials.
